Clinical trial NCT01619150 - References

Osteoarthritis — A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain

Citation(s)

•   Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al
  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986 Aug;29(8):1039-49.
•   Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T
  Sensitization in patients with painful knee osteoarthritis. Pain. 2010 Jun;149(3):573-81. doi: 10.1016/j.pain.2010.04.003. Epub 2010 Apr 24.
•   Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW
  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988 Dec;15(12):1833-40.
•   Brooks P, Kubler P
  Etoricoxib for arthritis and pain management. Ther Clin Risk Manag. 2006 Mar;2(1):45-57.
•   Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ
  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.
•   Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, Erdmann E, Laine L; MEDAL Steering Committee
  Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet. 2006 Nov 18;368(9549):1771-81.
•   Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC
  Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996 Oct;67(2-3):267-73.
•   Felson DT
  Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther. 2009;11(1):203. doi: 10.1186/ar2531. Epub 2009 Jan 30. Review.
•   Freynhagen R, Baron R, Gockel U, Tölle TR
  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006 Oct;22(10):1911-20.
•   Freynhagen R, Rolke R, Baron R, Tölle TR, Rutjes AK, Schu S, Treede RD
  Pseudoradicular and radicular low-back pain--a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain. 2008 Mar;135(1-2):65-74. Epub 2007 Jun 13.
•   Graven-Nielsen T, Arendt-Nielsen L
  Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010 Oct;6(10):599-606. doi: 10.1038/nrrheum.2010.107. Epub 2010 Jul 27. Review.
•   Guy and Bonato (Eds)
  Manual for the ECDEU Assessment Battery. 2nd revised edition. Chevy Chase, MD: National Institute of Mental Health 1976.
•   Imamura M, Imamura ST, Kaziyama HH, Targino RA, Hsing WT, de Souza LP, Cutait MM, Fregni F, Camanho GL
  Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum. 2008 Oct 15;59(10):1424-31. doi: 10.1002/art.24120.
•   Jansen JP, Gaugris S, Choy EH, Ostor A, Nash JT, Stam W
  Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis. Pharmacoeconomics. 2010;28(4):323-44. doi: 10.2165/11314690-000000000-00000.
•   Jespersen A, Dreyer L, Kendall S, Graven-Nielsen T, Arendt-Nielsen L, Bliddal H, Danneskiold-Samsoe B
  Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgia. Pain. 2007 Sep;131(1-2):57-62. Epub 2007 Jan 25.
•   Kristiansen K, Lyngholm-Kjaerby P, Moe C
  Introduction and Validation of DoloTest(®): a new health-related quality of life tool used in pain patients. Pain Pract. 2010 Sep-Oct;10(5):396-403. doi: 10.1111/j.1533-2500.2010.00366.x.
•   Lin HY, Cheng TT, Wang JH, Lee CS, Chen MH, Lei V, Lac C, Gammaitoni AR, Smugar SS, Chen WJ
  Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial. Int J Rheum Dis. 2010 May;13(2):144-50. doi: 10.1111/j.1756-185X.2010.01468.x.
•   Moore RA, Moore OA, Derry S, McQuay HJ
  Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. Arthritis Res Ther. 2008;10(2):R39. doi: 10.1186/ar2394. Epub 2008 Apr 2.
•   Renner B, Zacher J, Buvanendran A, Walter G, Strauss J, Brune K
  Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery--a pilot study. Naunyn Schmiedebergs Arch Pharmacol. 2010 Feb;381(2):127-36. doi: 10.1007/s00210-009-0482-0. Epub 2010 Jan 6.
•   Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM
  A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain. 2006 Jul;123(1-2):28-36. Epub 2006 Apr 4.
•   Staahl C, Reddy H, Andersen SD, Arendt-Nielsen L, Drewes AM
  Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics. Basic Clin Pharmacol Toxicol. 2006 Feb;98(2):201-11.
•   Tan G, Jensen MP, Thornby JI, Shanti BF
  Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004 Mar;5(2):133-7.
•   Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P
  Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011 Jan 11;342:c7086. doi: 10.1136/bmj.c7086. Review.
•   Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J
  Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003 Dec;106(3):337-45. Review.
•   van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP
  Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage. 2010 May;18(5):605-12. doi: 10.1016/j.joca.2010.01.012. Epub 2010 Feb 6. Review.
•   You HJ, Mørch CD, Chen J, Arendt-Nielsen L
  Differential antinociceptive effects induced by a selective cyclooxygenase-2 inhibitor (SC-236) on dorsal horn neurons and spinal withdrawal reflexes in anesthetized spinal rats. Neuroscience. 2003;121(2):459-72.

A Single Center, Randomized, Double-blind, Placebo-controlled 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain.

Details for clinical trial NCT01619150